1. Antibiotics: FDA has encouraged development, but needs to clarify the role of draft guidance and develop qualified infectious disease product guidance : report to Congressional requesters Publication: Washington, D.C. : U.S. Government Accountability Office, January 2017 Subject(s): Anti-Bacterial Agents -- therapeutic useDrug ApprovalDrug IndustryDrugs, InvestigationalInvestigational New Drug ApplicationDrug Resistance, BacterialGuidelines as TopicHumansUnited StatesUnited States. Food and Drug Administration.
